
MorphoSys AG MOR
Geschäftsbericht 2023
hinzugefügt 27.12.2025
MorphoSys AG ROE 2011-2026 | MOR
ROE Jährlich MorphoSys AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 15.76 | -26.1 | -11.5 | -19.47 | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 15.76 | -26.1 | -10.33 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Adagene
ADAG
|
-66.16 | $ 2.4 | -3.61 % | $ 135 M | ||
|
Aptorum Group Limited
APM
|
-20.19 | $ 0.97 | 0.81 % | $ 5.29 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.62 | 1.91 % | $ 8.71 B | ||
|
Biogen
BIIB
|
9.76 | $ 172.5 | 0.53 % | $ 25.1 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
BioNTech SE
BNTX
|
1.11 | $ 117.41 | 1.23 % | $ 27.2 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Catalyst Biosciences
CBIO
|
540.06 | $ 12.1 | -5.47 % | $ 797 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Cellectis S.A.
CLLS
|
-26.25 | $ 4.16 | -5.88 % | $ 116 M | ||
|
BioXcel Therapeutics
BTAI
|
64.02 | $ 1.79 | -1.92 % | $ 4.54 M | ||
|
BioLineRx Ltd.
BLRX
|
-136.27 | $ 2.98 | -3.75 % | $ 908 M | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-43.41 | $ 231.73 | -1.55 % | $ 5 B | ||
|
Burford Capital Limited
BUR
|
10.1 | $ 9.72 | -0.31 % | $ 1.57 B | ||
|
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | ||
|
Cytokinetics, Incorporated
CYTK
|
435.49 | $ 63.82 | 0.65 % | $ 7.15 M | ||
|
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-0.35 | $ 67.09 | 0.06 % | $ 8.97 B | ||
|
Compugen Ltd.
CGEN
|
-25.92 | $ 2.05 | -2.15 % | $ 184 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 4.41 | -1.34 % | $ 9.6 B | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-288.19 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
21.78 | $ 26.4 | 1.85 % | $ 1.28 B | ||
|
Coherus BioSciences
CHRS
|
122.99 | $ 2.27 | 10.19 % | $ 214 M | ||
|
Amneal Pharmaceuticals
AMRX
|
67.61 | $ 13.54 | 1.12 % | $ 4.18 B | ||
|
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Aptose Biosciences
APTO
|
559.76 | - | -45.71 % | $ 1.2 M | ||
|
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | ||
|
Athira Pharma
ATHA
|
-216.19 | - | - | $ 269 M | ||
|
Celldex Therapeutics
CLDX
|
-21.13 | $ 26.48 | 2.16 % | $ 1.71 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | ||
|
Aytu BioScience
AYTU
|
-71.51 | $ 2.73 | 1.11 % | $ 17.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
20.44 | $ 94.12 | 1.25 % | $ 96.9 B | ||
|
Arena Pharmaceuticals
ARNA
|
-91.56 | - | -6.81 % | $ 3.04 B |